Skip to Main Content

Paper Details

Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol
5
2023
Author NameAffiliation
Elizabeth Garrett-MayerAmerican Society of Clinical Oncology
Jordi RodonUniversity of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2